MELDlaskenta

MELDlaskenta is a term that refers to the calculation or estimation of the Model for End-Stage Liver Disease (MELD) score. The MELD score is a numerical scale used to prioritize patients for liver transplantation. It is a prognostic indicator that predicts the short-term mortality risk of individuals with end-stage liver disease. The score is calculated using a formula that takes into account a patient's serum bilirubin, serum creatinine, and the international normalized ratio (INR) of prothrombin time. In some cases, a patient's sodium level may also be included in the calculation, leading to a MELD-Na score.

The MELD score ranges from 6 to 40, with higher scores indicating a greater likelihood of death within a three-month period without a transplant. This scoring system was developed to provide a more objective and standardized method for organ allocation. It aims to ensure that those most in need of a liver transplant are placed higher on the waiting list. The MELDlaskenta is performed regularly by healthcare professionals to monitor a patient's condition and update their position on the transplant list as their score changes. The accuracy and implementation of MELDlaskenta are crucial components of the liver transplant allocation system in many countries.